Enteric Disease Testing Market in India

Enteric Disease Testing in India Trends and Forecast

The future of the enteric disease testing market in India looks promising, with opportunities in the water and food markets. The global enteric disease testing market is expected to reach an estimated $5.1 billion by 2031 with a CAGR of 3.5% from 2025 to 2031. The enteric disease testing market in India is also forecasted to witness strong growth over the forecast period. The major drivers for this market are the rising number of innovations and technological advancements in enteric disease testing devices, increasing focus on sample utilization, and growing advancements for quicker, proficient, and cheaper computing hardware tied with better network connectivity.

• Lucintel forecasts that, within the technology category, traditional testing will remain the largest segment over the forecast period due to growing demand for processed and convenience food, as well as increasing incidences of enteric diseases.

Emerging Trends in the Enteric Disease Testing Market in India

India, with its large population and diverse healthcare needs, faces significant challenges in managing enteric diseases, which are caused by pathogens such as bacteria, viruses, and parasites. As India works to improve public health and expand healthcare access, emerging trends in enteric disease testing are reshaping the diagnostic landscape. Advances in diagnostic technologies, government initiatives, and growing awareness among the public are all contributing to improvements in the efficiency, speed, and accessibility of enteric disease testing in the country.

• Rise in Rapid Diagnostic Testing: Rapid diagnostic tests (RDTs) are increasingly being adopted in India to detect enteric diseases at the point of care. These tests provide quick results within minutes, enabling faster diagnosis and reducing the burden on centralized labs. The widespread use of RDTs in both urban and rural healthcare settings ensures quicker isolation of infected individuals, improving infection control and treatment, and reducing the spread of diseases like cholera and typhoid.
• Focus on Molecular Diagnostics: The adoption of molecular diagnostic techniques, such as PCR and next-generation sequencing, is growing in India. These methods offer higher accuracy, sensitivity, and the ability to detect multiple pathogens in a single test. The use of molecular diagnostics has allowed for more accurate detection of enteric diseases like Salmonella and E. coli, leading to better-targeted treatments and improved patient outcomes. These technologies are gaining traction in urban and tertiary healthcare centers.
• Integration of Digital Health Solutions: India is increasingly integrating digital health solutions into the healthcare ecosystem, including telemedicine, remote testing, and health data analytics. These solutions allow patients, especially in rural or underserved areas, to access enteric disease testing remotely. Digital platforms enable the timely reporting of test results and facilitate virtual consultations with doctors, enhancing patient care and improving the overall diagnostic process. These innovations contribute to expanded access to healthcare and more efficient disease management.
• Increase in Point-of-Care Testing: Point-of-care (POC) testing is becoming increasingly common in India, particularly in rural regions where access to centralized laboratories is limited. POC tests for enteric diseases such as diarrhea and foodborne infections provide instant results, reducing delays in diagnosis. This trend has enabled healthcare workers to conduct tests in remote areas and provide immediate treatment, improving health outcomes in underserved populations. POC testing also supports disease surveillance, aiding public health authorities in controlling outbreaks more efficiently.
• Government Initiatives for Better Disease Surveillance: The Indian government is increasingly prioritizing enteric disease surveillance, with a focus on early detection and rapid response. Initiatives such as the National Health Mission and the Integrated Disease Surveillance Program (IDSP) aim to improve disease monitoring and testing across the country. Government efforts to improve access to diagnostics and increase awareness are helping to reduce the incidence of enteric diseases, improve timely interventions, and boost testing coverage in rural areas, where healthcare access has traditionally been limited.

Emerging trends in the enteric disease testing market in India are reshaping the healthcare landscape, with a focus on rapid diagnostics, molecular testing, digital health integration, and point-of-care solutions. Government initiatives and improved access to diagnostics, particularly in rural areas, are helping to address gaps in healthcare delivery. These trends contribute to better disease control, more timely interventions, and improved health outcomes, reflecting a growing commitment to tackling enteric diseases at both the individual and population levels.

Recent Developments in the Enteric Disease Testing Market in India

In recent years, India has witnessed a surge in developments aimed at improving the detection and management of enteric diseases, driven by advances in diagnostics, increased public awareness, and government support. These developments aim to tackle the growing burden of enteric diseases, which continue to affect millions of Indians annually. The enteric disease testing market is evolving as a result of these efforts, with key advancements contributing to faster diagnosis, better disease surveillance, and enhanced patient outcomes.

• Launch of Rapid Diagnostic Kits for Common Enteric Diseases: Recently, India has seen the launch of new rapid diagnostic kits specifically designed to detect common enteric pathogens like E. coli, Salmonella, and Vibrio cholerae. These kits allow for fast and accurate diagnosis at the point of care, reducing the time needed for testing and ensuring quicker interventions. By making testing more accessible, especially in rural and remote areas, these kits are helping to reduce disease transmission rates and improve patient management.
• Expansion of Molecular Diagnostics in Tier 2 and Tier 3 Cities: Molecular diagnostic platforms, such as PCR, have expanded beyond metropolitan areas to Tier 2 and Tier 3 cities in India. These technologies provide more accurate and sensitive results than traditional diagnostic methods, enabling better detection of pathogens that cause enteric diseases. This expansion is helping healthcare facilities in smaller cities improve diagnostic accuracy, leading to better-targeted treatments and improving overall healthcare delivery.
• Public-Private Partnerships to Enhance Diagnostics: Public-private partnerships (PPPs) are playing a critical role in expanding access to enteric disease testing in India. Collaborations between government bodies and private healthcare organizations are driving the development of new diagnostic platforms and expanding testing coverage. These partnerships have been crucial in making cutting-edge diagnostics more affordable and accessible to a larger segment of the population, particularly in underserved regions of the country.
• Introduction of Mobile Testing Units in Remote Areas: in a bid to improve access to testing in remote and underserved regions, mobile testing units have been introduced to conduct enteric disease testing on-site. These units, equipped with the latest diagnostic technologies, travel to rural areas, ensuring that people in these regions have access to quality healthcare services. This innovation is reducing the logistical barriers to testing, helping detect diseases earlier, and preventing outbreaks in hard-to-reach areas.
• Strengthened Government Initiatives to Combat Diarrheal Diseases: The Indian government has introduced a series of initiatives aimed at reducing the burden of diarrheal diseases, which are among the most common enteric diseases in the country. These initiatives include expanding access to vaccines, improving sanitation and hygiene, and increasing funding for diagnostic testing. These efforts are improving public health outcomes, reducing the incidence of enteric diseases, and strengthening India’s ability to manage and prevent outbreaks.

Recent developments in India’s enteric disease testing market, including the launch of rapid diagnostic kits, the expansion of molecular diagnostics, and mobile testing units, are transforming the healthcare landscape. Public-private partnerships and government initiatives are also contributing to better disease management and more accessible testing. These developments are helping India make significant progress in tackling enteric diseases and improving health outcomes for the population.

Strategic Growth Opportunities for Enteric Disease Testing Market in India

The enteric disease testing market in India is experiencing significant growth, driven by technological advancements, evolving healthcare needs, and increasing government support. As the country continues to address the high burden of enteric diseases, several key growth opportunities across various applications are emerging. These opportunities range from the adoption of new diagnostic technologies to the expansion of testing infrastructure, which will help improve disease detection, reduce transmission, and ultimately enhance public health.

• Expansion of Point-of-Care (POC) Testing in Rural Areas: There is a significant opportunity to expand point-of-care testing (POC) in rural areas where healthcare infrastructure is often lacking. POC tests for enteric diseases allow for rapid diagnosis and treatment at the patient’s location, avoiding delays in transportation to centralized laboratories. By expanding POC testing, India can improve access to diagnostics in underserved regions, leading to faster interventions and better disease management outcomes.
• Adoption of Molecular Diagnostic Technologies: As molecular diagnostic technologies like PCR and next-generation sequencing become more affordable, they present a substantial growth opportunity for the enteric disease testing market in India. These technologies provide more accurate, sensitive, and faster results, making it easier to detect a wide range of enteric pathogens. Adoption of these technologies across healthcare settings, especially in non-metropolitan areas, will enhance the speed and accuracy of diagnoses, improving treatment outcomes and helping to control outbreaks more effectively.
• Development of Digital Health Platforms for Remote Testing: With the rise of telemedicine and digital health solutions, there is a growth opportunity to integrate digital health platforms for remote testing and virtual consultations. These platforms can offer enteric disease testing kits that patients can use at home and send their samples remotely for analysis. Digital health solutions will expand testing access in rural and remote areas, improve patient engagement, and streamline the overall healthcare delivery process.
• Increase in Government Funding for Diagnostics: Increased government investment in healthcare infrastructure and diagnostics is an important growth opportunity. The government is already working to expand diagnostic coverage and improve disease surveillance, and further funding could support the development of new testing technologies, expand the reach of diagnostics, and enhance disease monitoring. Continued government funding will drive the growth of the enteric disease testing market, particularly in underserved areas.
• Public Health Education and Awareness Programs: There is a growth opportunity in expanding public health education and awareness programs about the importance of early diagnosis and treatment of enteric diseases. By educating the public about hygiene, sanitation, and the availability of diagnostic services, India can increase the demand for testing services and promote healthier behaviors. These programs will help reduce disease transmission and increase public engagement in early diagnosis and treatment.

Strategic growth opportunities in the enteric disease testing market in India, such as expanding POC testing in rural areas, adopting molecular diagnostic technologies, and integrating digital health platforms, will improve the accessibility, accuracy, and efficiency of disease detection. Government funding and public health education programs will further strengthen the healthcare infrastructure, contributing to better public health outcomes and greater disease control.

Enteric Disease Testing Market in India Driver and Challenges

The enteric disease testing market in India is influenced by a range of drivers and challenges that include technological advancements, economic factors, and regulatory considerations. While drivers like innovation in diagnostics and government investment in healthcare infrastructure are fueling market growth, challenges such as affordability, accessibility, and healthcare system disparities remain significant barriers. Understanding these factors is essential for navigating the complexities of the Indian market and ensuring effective enteric disease management.

The factors responsible for driving the enteric disease testing market in India include:
• Technological Innovations in Diagnostics: Advances in diagnostic technologies, such as rapid diagnostic tests (RDTs), PCR-based testing, and multiplex platforms, are significantly driving the growth of the enteric disease testing market. These technologies provide more accurate, faster results and are increasingly affordable, making them accessible in both urban and rural healthcare settings. As technology continues to evolve, diagnostic capabilities will improve, driving further market growth and enhancing disease management.
• Government Support for Public Health Initiatives: The Indian government’s investment in healthcare infrastructure and public health programs is a major driver of the enteric disease testing market. Programs like the National Health Mission and Integrated Disease Surveillance Program (IDSP) are helping expand testing coverage, enhance disease surveillance, and improve access to diagnostics. Increased government funding and support for diagnostics are improving healthcare delivery and enabling faster responses to enteric disease outbreaks.
• Growing Health Awareness: As health awareness increases, particularly regarding foodborne diseases and hygiene practices, more people are seeking early diagnosis for enteric diseases. Public awareness campaigns and educational programs are helping individuals understand the importance of timely testing, leading to an increase in demand for testing services. Greater awareness is driving public demand for enteric disease testing, which in turn is propelling market growth.
• Improved Healthcare Infrastructure: India’s healthcare infrastructure is rapidly improving, with new diagnostic facilities, better-trained personnel, and expanded healthcare access, particularly in rural areas. This improvement is enabling broader testing capabilities, increasing the availability of testing services across the country. The expansion of testing infrastructure supports faster disease detection, which is essential for controlling outbreaks and improving health outcomes.
• Rise in Travel and Global Trade: As travel and trade increase, so does the risk of enteric disease transmission across borders. This global connectivity drives the demand for effective enteric disease testing systems, particularly in areas with high volumes of international visitors or food imports. Enhancing diagnostic capabilities helps India better monitor and manage enteric diseases and prevent international outbreaks.

Challenges in the enteric disease testing market in India are:
• High Costs of Advanced Diagnostics: Despite technological advancements, the high cost of diagnostic tests remains a significant challenge in India. PCR tests and other advanced diagnostics are expensive, limiting their accessibility in low-resource settings. The affordability gap hinders widespread adoption, particularly in rural areas, where access to advanced healthcare services is already limited.
• Healthcare Disparities Between Urban and Rural Areas: India faces considerable healthcare disparities between urban and rural areas, particularly when it comes to access to diagnostic testing. Rural areas often lack the infrastructure to support high-quality testing, leading to delayed diagnoses and treatment. Addressing these disparities is essential for improving overall health outcomes and ensuring that enteric disease testing is available to all populations.
• Regulatory Hurdles in Diagnostic Approval: Regulatory approval for new diagnostic tools and technologies in India can be slow and cumbersome. The complex regulatory environment for diagnostics can delay the introduction of new testing methods, hindering innovation and market growth. Streamlining the regulatory process and creating clearer pathways for new technologies will help accelerate the adoption of more efficient testing methods.

The drivers and challenges impacting the enteric disease testing market in India include advancements in diagnostics, government initiatives, and increased awareness. However, challenges such as high costs, healthcare disparities, and regulatory hurdles must be addressed to unlock the full potential of the market. By overcoming these challenges, India can improve its enteric disease testing capabilities, enhance public health, and better manage disease outbreaks.

List of Enteric Disease Testing Market in India Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, enteric disease testing companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the enteric disease testing companies profiled in this report include:
• Company 1
• Company 2
• Company 3
• Company 4
• Company 5
• Company 6
• Company 7
• Company 8
• Company 9

Enteric Disease Testing Market in India by Segment

The study includes a forecast for the enteric disease testing market in India by technology and end use.

Enteric Disease Testing Market in India by Technology [Analysis by Value from 2019 to 2031]:

• Traditional
• Rapid
• Convenience-Based
• Polymerase Chain Reaction
• Immunoassay
• Chromatography & Spectrometry

Enteric Disease Testing Market in India by End Use [Analysis by Value from 2019 to 2031]:

• Food
• Water

Features of the Enteric Disease Testing Market in India

Market Size Estimates: Enteric disease testing in India market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends and forecasts by various segments.
Segmentation Analysis: Enteric disease testing in India market size by technology and end use in terms of value ($B).
Growth Opportunities: Analysis of growth opportunities in different technologies and end uses for the enteric disease testing in India.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the enteric disease testing in India.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q.1 What are the major drivers influencing the growth of the enteric disease testing market in India?
Answer: The major drivers for this market are the rising number of innovations and technological advancements in enteric disease testing devices, increasing focus on sample utilization, and growing advancements for quicker, proficient, and cheaper computing hardware tied with better network connectivity.
Q2. What are the major segments for enteric disease testing market in India?
Answer: The future of the enteric disease testing market in India looks promising, with opportunities in the water and food markets.
Q3. Which enteric disease testing market segment in India will be the largest in future?
Answer: Lucintel forecasts that traditional testing will remain the largest segment over the forecast period due to growing demand for processed and convenience food, as well as increasing incidences of enteric diseases.
Q4. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 10 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the enteric disease testing market in India by technology (traditional, rapid, convenience-based, polymerase chain reaction, immunoassay, and chromatography & spectrometry) and end use (food and water)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.4. What are the business risks and competitive threats in this market?
Q.5. What are the emerging trends in this market and the reasons behind them?
Q.6. What are some of the changing demands of customers in the market?
Q.7. What are the new developments in the market? Which companies are leading these developments?
Q.8. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.9. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.10. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Enteric Disease Testing Market in India, Enteric Disease Testing Market in India Size, Enteric Disease Testing Market in India Growth, Enteric Disease Testing Market in India Analysis, Enteric Disease Testing Market in India Report, Enteric Disease Testing Market in India Share, Enteric Disease Testing Market in India Trends, Enteric Disease Testing Market in India Forecast, Enteric Disease Testing Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.